THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Acquisitions of businesses amounting to € 122.4 million result<br />
from the acquisition of the flavor business from Chr. Hansen and<br />
of the fragrance businesses from Intercontinental Fragrances and<br />
Manheimer Fragrances.<br />
The amortization of recipes is allocated to production and is therefore<br />
included in the cost of sales. The amortization of other intangible<br />
assets is allocated to the respective functional areas included<br />
in the income statement.<br />
8.11. Impairment Testing of Goodwill, Recipes and Trademarks<br />
with Indefinite Useful Lives<br />
Goodwill arising through business combinations has been allocated<br />
to the following two cash-generating units, which are tested<br />
for impairment:<br />
› Flavor & Nutrition<br />
› Scent & Care<br />
The recoverable amount of a business division is determined based<br />
on the value in use as at September 30, 2008. Cash flow projections<br />
are based on the Group’s three year financial planning. A net<br />
tax discounting factor of 8.0% (prior year: 7.6%) was used to discount<br />
cash flow projections.<br />
The carrying amount of goodwill as at September 30, 2008<br />
amounted to € 309.3 million in the Flavor & Nutrition division and<br />
€ 156.1 million in the Scent & Care division. As compared to the<br />
balance sheet reporting date as at December 31, 2008, the estimated<br />
goodwill recognized for the Manheimer acquisition was then<br />
some € 10.6 million ($ 15.0 million) higher. Within the context of<br />
a purchase price reduction made in December 2008, a correspondingly<br />
lower goodwill was derived at the balance sheet reporting<br />
date.<br />
As in the previous year, the total amount (€ 62.1 million) relating to<br />
recipes with indefinite useful lives has been allocated to the Scent<br />
& Care division. In this case, an impairment test was also carried<br />
out as of September 30, 2008, at the level of the cash-generating<br />
unit with the result that no impairment requirement was identified.<br />
Trademarks with indefinite useful lives were also tested for impairment<br />
as at September 30, 2008. No impairment was identified.<br />
An impairment loss of € 35.7 million was recognized in 2003 with<br />
respect to goodwill attributed to the Scent & Care division. The impairment<br />
related to the former Aroma Chemicals business sector.<br />
Key assumptions used in determining the<br />
recoverable amount<br />
The Group determined the value in use as the recoverable amount.<br />
The key assumptions are described below which provided the basis<br />
for management’s cash flow projections used in making the impairment<br />
tests for goodwill, recipes and trademarks.<br />
The value in use was calculated using the discounted cash flow<br />
(DCF) method under which free cash flows are discounted using<br />
the weighted average cost of capital (WACC).<br />
The Group has calculated the cash flows of the individual divisions<br />
during the period from 2008 to 2011 based on varying growth<br />
rates. For 2009, the data used was based on the detailed budget<br />
data for 2009, whereas for the years 2010 and 2011 a constant<br />
growth rate of 4.5% was used for the Flavor & Nutrition division<br />
and a constant growth rate of 3.5% was used for the Scent & Care<br />
division. An overall growth rate of 0.5% was assumed for the year<br />
2012.<br />
The WACC comprises a risk-free interest rate of 4.8%, which is derived<br />
from the interest rate on German federal government bonds,<br />
and a market risk premium of 5.0%. The unlevered beta factor is<br />
0.75 and the levered beta factor is 0.9. The estimated cost of equity<br />
is 9.3% and the cost of debt is 6.3%.<br />
The ICF and Manheimer acquisitions (see note 8.13) were included<br />
in the impairment test as at September 30, 2008.<br />
Applying the assumptions described above, the impairment test<br />
carried out as at September 30, 2008, confirmed that there was<br />
no impairment of either goodwill or recipes. The recoverable<br />
amount was higher than the respective carrying amounts in both<br />
business divisions.<br />
126 Annual Report 2008 <strong>Symrise</strong> AG